Key result
Only ~13% of patients identified as high-risk by Padua score receive VTE prophylaxis.
Why the study?
The Padua prediction score predicts patients at high risk for VTE, and this study was conducted to assess the score for receiving VTE prophylaxis.
What is the rate of appropriate VTE prophylaxis according to the Padua prediction score in hospitalized internal medicine patients?
Cohort (n=300)
No
What is the rate of appropriate VTE prophylaxis according to the Padua prediction score in hospitalized internal medicine patients?
The study highlights a significant underutilization of VTE prophylaxis in high-risk hospitalized patients despite identification by the Padua prediction score.
Answers are grounded in this paper and cite their sources.
Low prophylaxis rates in PPS high-risk patients signal implementation gaps; leaves open whether routine scoring improves VTE outcomes in observational settings.
Background: Padua prediction score (PPS) predicts high risk patients of vein thromboembolism (VTE). Objectives: This study was conducted to assess Padua prediction score in order to receive prophylaxis of VTE. Methods: This prospective cohort study was conducted between 300 patients admitted to the internal ward of Imam Reza Hospital who stayed longer than three days in 2017. The initial questionnaire of PPS done for patients and telephone follow up after three months was used to gather data. For the statistical analysis, SPSS software version 22 using chi-square test was used. Results: Out of 300 patients, according to the Padua model, 266 patients were in a high risk of VTE, 35 received prophylaxis. Only 13.15% of high risk groups received prophylaxis. Around 87% of high risk groups did not receive prophylaxis. After six months follow up, 18 patients got VTE, three of them being in a high-risk group and received prophylaxis. There was a significant difference between PPS and cancer in receiving prophylaxis (P < 0.05). Conclusions: Receiving prophylaxis in the high-risk group was low. Cancer patients needed more in receiving prophylaxis, according to categories of cancer/not cancer, however, they did not receive it and PPS could recognize them.
No takes yet. Share an insight, caveat, or question.
Joharimoghadam et al. (2018) conducted a cohort in Vein thromboembolism (VTE) (n=300). High risk of VTE (Padua prediction score) vs. Low risk of VTE was evaluated on Receipt of VTE prophylaxis. Only 13.15% of patients identified as high risk for VTE by the Padua prediction score received prophylaxis, and 18 patients developed VTE over 6 months of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: